12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

• Vaccitech (NASDAQ:VACC) shares rose 8.5% to $3.2 during Friday's after-market session. The company's market cap stands at $119.3 million.
• Calithera Biosciences (NASDAQ:CALA) shares rose 7.34% to $0.39. The market value of their outstanding shares is at $1.8 million.
• Ocuphire Pharma (NASDAQ:OCUP) shares increased by 6.45% to $3.63. The market value of their outstanding shares is at $75.5 million.
• Creative Medical Tech (NASDAQ:CELZ) stock increased by 6.12% to $0.59. The company's market cap stands at $8.2 million.
• Sharps Technology (NASDAQ:STSS) shares rose 5.88% to $1.44. The company's market cap stands at $13.5 million.
• Summit Therapeutics (NASDAQ:SMMT) shares increased by 4.95% to $3.39. Trading volume for this security closed at 174.7K, accounting for 1.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $716.3 million.

Losers

• Akanda (NASDAQ:AKAN) stock declined by 9.9% to $0.31 during Friday's after-market session. Akanda's trading volume hit 12.9 million shares by close, accounting for 440.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $10.5 million.
• Heart Test Laboratories (NASDAQ:HSCS) stock declined by 9.76% to $0.79. The market value of their outstanding shares is at $6.5 million.
• Zynerba Pharmaceuticals (NASDAQ:ZYNE) shares declined by 6.48% to $0.62. The company's market cap stands at $29.1 million.
• Quince Therapeutics (NASDAQ:QNCX) shares decreased by 5.56% to $1.02. Today's trading volume for this security ended up closing at 17.4 million shares, which is 7279.1 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $36.8 million.
• Tivic Health Systems (NASDAQ:TIVC) shares declined by 5.41% to $0.7. The market value of their outstanding shares is at $6.7 million.
• NanoVibronix (NASDAQ:NAOV) shares fell 5.01% to $0.3. The company's market cap stands at $9.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.